XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed consolidated statements of stockholders' equity (unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance at Mar. 31, 2021 $ 269,646 $ 504 $ 774,441 $ (505,299)
Beginning balance (in shares) at Mar. 31, 2021   50,400,510    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 8,276     8,276
Stock-based compensation 4,190   4,190  
Exercise of stock options and vesting of restricted stock 510 $ 4 506  
Exercise of stock options and vesting of restricted stock (in shares)   358,575    
Ending balance at Jun. 30, 2021 282,622 $ 508 779,137 (497,023)
Ending balance (in shares) at Jun. 30, 2021   50,759,085    
Beginning balance at Mar. 31, 2021 269,646 $ 504 774,441 (505,299)
Beginning balance (in shares) at Mar. 31, 2021   50,400,510    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 20,214      
Ending balance at Dec. 31, 2021 305,468 $ 512 790,041 (485,085)
Ending balance (in shares) at Dec. 31, 2021   51,134,322    
Beginning balance at Jun. 30, 2021 282,622 $ 508 779,137 (497,023)
Beginning balance (in shares) at Jun. 30, 2021   50,759,085    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,724     5,724
Stock-based compensation 5,033   5,033  
Exercise of stock options and vesting of restricted stock 714 $ 3 711  
Exercise of stock options and vesting of restricted stock (in shares)   290,418    
Ending balance at Sep. 30, 2021 294,093 $ 511 784,881 (491,299)
Ending balance (in shares) at Sep. 30, 2021   51,049,503    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,214     6,214
Stock-based compensation 5,149   5,149  
Exercise of stock options and vesting of restricted stock 12 $ 1 11  
Exercise of stock options and vesting of restricted stock (in shares)   84,819    
Ending balance at Dec. 31, 2021 305,468 $ 512 790,041 (485,085)
Ending balance (in shares) at Dec. 31, 2021   51,134,322    
Beginning balance at Mar. 31, 2022 312,429 $ 515 795,443 (483,529)
Beginning balance (in shares) at Mar. 31, 2022   51,524,307    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 14,469     14,469
Stock-based compensation 6,549   6,549  
Exercise of stock options and vesting of restricted stock 2 $ 2    
Exercise of stock options and vesting of restricted stock (in shares)   558,336    
Ending balance at Jun. 30, 2022 333,449 $ 517 801,992 (469,060)
Ending balance (in shares) at Jun. 30, 2022   52,082,643    
Beginning balance at Mar. 31, 2022 312,429 $ 515 795,443 (483,529)
Beginning balance (in shares) at Mar. 31, 2022   51,524,307    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 45,284      
Ending balance at Dec. 31, 2022 385,304 $ 528 823,021 (438,245)
Ending balance (in shares) at Dec. 31, 2022   52,823,660    
Beginning balance at Jun. 30, 2022 333,449 $ 517 801,992 (469,060)
Beginning balance (in shares) at Jun. 30, 2022   52,082,643    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 11,710     11,710
Stock-based compensation 8,022   8,022  
Exercise of stock options and vesting of restricted stock 3,779 $ 8 3,771  
Exercise of stock options and vesting of restricted stock (in shares)   471,966    
Ending balance at Sep. 30, 2022 356,960 $ 525 813,785 (457,350)
Ending balance (in shares) at Sep. 30, 2022   52,554,609    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 19,105     19,105
Stock-based compensation 7,239   7,239  
Exercise of stock options and vesting of restricted stock 2,000 $ 3 1,997  
Exercise of stock options and vesting of restricted stock (in shares)   269,051    
Ending balance at Dec. 31, 2022 $ 385,304 $ 528 $ 823,021 $ (438,245)
Ending balance (in shares) at Dec. 31, 2022   52,823,660